RED LIGHT HOLLAND CORP. (F:4YX) — Market Cap & Net Worth
Market Cap & Net Worth: RED LIGHT HOLLAND CORP. (4YX)
RED LIGHT HOLLAND CORP. (F:4YX) has a market capitalization of $6.62 Million (€5.66 Million) as of September 17, 2026. Listed on the F stock exchange, this Germany-based company holds position #28100 globally and #2413 in its home market, demonstrating a 23.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RED LIGHT HOLLAND CORP.'s stock price €0.01 by its total outstanding shares 595727901 (595.73 Million). Also see 4YX total asset value for a full breakdown of the balance sheet.
RED LIGHT HOLLAND CORP. Market Cap History: 2020 to 2026
RED LIGHT HOLLAND CORP.'s market capitalization history from 2020 to 2026. Data shows change from $142.08 Million to $6.62 Million (-31.54% CAGR). Also see 4YX cash generation efficiency for how efficiently the company converts equity into cash flow.
RED LIGHT HOLLAND CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RED LIGHT HOLLAND CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check RED LIGHT HOLLAND CORP. share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.58x
RED LIGHT HOLLAND CORP.'s market cap is 1.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $39.35 Million | $2.33 Million | -$14.37 Million | 16.92x | N/A |
| 2023 | $24.38 Million | $3.95 Million | -$5.40 Million | 6.17x | N/A |
| 2024 | $17.41 Million | $4.75 Million | -$7.63 Million | 3.66x | N/A |
| 2025 | $6.96 Million | $4.94 Million | -$4.04 Million | 1.41x | N/A |
| 2026 | $6.62 Million | $4.20 Million | -$6.10 Million | 1.58x | N/A |
Competitor Companies of 4YX by Market Capitalization
Companies near RED LIGHT HOLLAND CORP. in the global market cap rankings as of September 17, 2026. Review RED LIGHT HOLLAND CORP. tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to RED LIGHT HOLLAND CORP. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
RED LIGHT HOLLAND CORP. Historical Marketcap From 2020 to 2026
Between 2020 and today, RED LIGHT HOLLAND CORP.'s market cap moved from $142.08 Million to $ 6.62 Million, with a yearly change of -31.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €6.62 Million | -5.00% |
| 2025 | €6.96 Million | -60.00% |
| 2024 | €17.41 Million | -28.57% |
| 2023 | €24.38 Million | -38.05% |
| 2022 | €39.35 Million | -43.50% |
| 2021 | €69.65 Million | -50.98% |
| 2020 | €142.08 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of RED LIGHT HOLLAND CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.62 Million USD |
| MoneyControl | $6.62 Million USD |
| MarketWatch | $6.62 Million USD |
| marketcap.company | $6.62 Million USD |
| Reuters | $6.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RED LIGHT HOLLAND CORP.
Rhelion Life Sciences Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. Its products… Read more